Proteome profiling by label‐free mass spectrometry reveals differentiated response of Campylobacter jejuni 81–176 to sublethal concentrations of bile acids.

Purpose Bile acids are crucial components of the intestinal antimicrobial defense and represent a significant stress factor for enteric pathogens. Adaptation processes of Campylobacter jejuni to this hostile environment are analyzed in this study by a proteomic approach. Experimental design Proteome profiling by label-free mass spectrometry (SWATH-MS) has been used to characterize the adaptation of C. jejuni to sublethal concentrations of seven bile acids. Results The bile acids with the lowest inhibitory concentration (IC50), deoxycholic and chenodeoxycholic acid, induce the most significant proteome changes. Overall a downregulation of all basic biosynthetic pathways and a general decrease in the transcription machinery are found. Concurrently, an induction of factors involved in detoxification of reactive oxygen species, protein folding, and bile acid exporting efflux pumps is detected. Exposure to deoxycholic and chenodeoxycholic acid results in an increased expression of components of the more energy-efficient aerobic respiration pathway, while the anaerobic branches of the electron transport chain are down-expressed. Conclusions and clinical relevance The results show that C. jejuni has a differentiated system of adaptation to bile acid stresses. The findings enhance the understanding of the pathogenesis of campylobacteriosis, especially for survival of C. jejuni in the human intestine, and may provide clues to future medical treatment

Decarbonising Urban Freight Transport: Experimentations in European Research Projects

One of the objectives of European research programs is to decarbonize freight transport while maintaining its competitiveness and economic strength, reduce negative externalities such as pollutant emissions, congestion and accidents, and foster innovation. Multiple initiatives have started in Europe to reach these objectives and this paper reviews some of these schemes in the field of urban freight transport. It is based mainly on 3 EC-funded projects (BESTFACT (2016), SOLUTION (2015) and SMARTFUSION (2016)). These 3 projects are either testing (Smartfusion) or examining and disseminating European ‘new solutions’ or ‘best practices’ in freight transport. The paper mainly focuses on the most decarbonizing solutions

Chiral recognition for the complexation dynamics of β-cyclodextrin with the enantiomers of 2-naphthyl-1-ethanol

The focus of this study is to understand the origin of the chiral recognition for a host–guest system containing complexes with different stoichiometries. Each enantiomer of 2-naphthyl-1-ethanol forms two different 1:1 complexes with β-cyclodextrin, leading to the formation of three different 2:2 complexes. One of these 2:2 complexes leads to excimer emission of the guest. Fluorescence studies were employed to determine the binding isotherms for the 1:1 and 2:2 complexes. No chiral discrimination was directly observed for the formation of the 1:1 complexes, while higher equilibrium constants (29% from binding isotherms and 40% from kinetic studies) were observed for the formation of the 2:2 complexes with (R)-2-naphthyl-1-ethanol when compared to the formation of the 2:2 complexes formed from (S)-2-naphthyl-1-ethanol. The relaxation kinetics was studied using stopped-flow experiments. The formation of the 2:2 complexes was followed by detecting the excimer emission from one of the 2:2 complexes. The relaxation kinetics was faster for (S)-2-naphthyl-1-ethanol, where a higher dissociation rate constant, by 47%, was observed, suggesting that the chiral discrimination occurs because the interaction between two cyclodextrins is more favorable for the complexes containing (R)-2-naphthyl-1-ethanol when compared to (S)-2-naphthyl-1-ethanol. The same overall equilibrium constants were observed for the 1:1 complexes with both enantiomers showing that at a given cyclodextrin concentration the sum of the two types of 1:1 complexes is the same for both enantiomers. However, analysis of the binding isotherms indicates that the ratio between the two different 1:1 complexes for each enantiomer was different for (R)- and (S)-2-naphthyl-1-ethanol

Germination of phagocytosed E. cuniculi spores does not significantly contribute to parasitophorous vacuole formation in J774 cells

The obligate intracellular microsporidia have developed a unique invasion mechanism to infect their host cells. Spores explosively evert a tube-like structure and extrude the infectious spore content through this organelle into the host cell. Spores from species of the genus Encephalitozoon were also shown to be efficiently internalized by phagocytosis, which led to the hypothesis that spore germination from inside a phagosome might contribute to the infection process. Here, we challenge this hypothesis by quantifying Encephalitozoon cuniculi infection rates of J774 cells that were incubated with the phagocytosis inhibitor cytochalasin D. We demonstrate that the invasion rate in cytochalasin D-treated cells is identical to untreated controls, although phagocytic uptake of E. cuniculi spores was less than 10% of control samples. This study suggests that germination of phagocytosed spores is not a significant infection mode for E. cuniculi

Nanogranular MgB2 thin films on SiC buffered Si substrates prepared by in-situ method

MgB2 thin films were deposited on SiC buffered Si substrates by sequential electron beam evaporation of B-Mg bilayer followed by in-situ annealing. The application of a SiC buffer layer enables the maximum annealing temperature of 830 C. The Transmission Electron Microscopy analysis confirms the growth of a nanogranular MgB2 film and the presence of a Mg2Si compound at the surface of the film. The 150-200 nm thick films show a maximum zero resistance critical temperature TC0 above 37 K and a critical current density JC ~ 106 A/cm2 at 11K.Comment: 7 pages, 6 figures, submitted to Applied Physics Letter

GlycomeDB—a unified database for carbohydrate structures

GlycomeDB integrates the structural and taxonomic data of all major public carbohydrate databases, as well as carbohydrates contained in the Protein Data Bank, which renders the database currently the most comprehensive and unified resource for carbohydrate structures worldwide. GlycomeDB retains the links to the original databases and is updated at weekly intervals with the newest structures available from the source databases. The complete database can be downloaded freely or accessed through a Web-interface (www.glycome-db.org) that provides flexible and powerful search functionalities

Quasi-fission reactions as a probe of nuclear viscosity

Fission fragment mass and angular distributions were measured from the ^{64}Ni+^{197}Au reaction at 418 MeV and 383 MeV incident energy. A detailed data analysis was performed, using the one-body dissipation theory implemented in the code HICOL. The effect of the window and the wall friction on the experimental observables was investigated. Friction stronger than one-body was also considered. The mass and angular distributions were consistent with one-body dissipation. An evaporation code DIFHEAT coupled to HICOL was developed in order to predict reaction time scales required to describe available data on pre-scission neutron multiplicities. The multiplicity data were again consistent with one-body dissipation. The cross-sections for touch, capture and quasi-fission were also obtained.Comment: 25 pages REVTeX, 3 tables, 13 figures, submitted to Phys. Rev

Excited States in 52Fe and the Origin of the Yrast Trap at I=12+

Excited states in 52Fe have been determined up to spin 10\hbar in the reaction 28Si + 28Si at 115 MeV by using \gamma-ray spectroscopy methods at the GASP array. The excitation energy of the yrast 10+ state has been determined to be 7.381 MeV, almost 0.5 MeV above the well known \beta+-decaying yrast 12+ state, definitely confirming the nature of its isomeric character. The mean lifetimes of the states have been measured by using the Doppler Shift Attenuation method. The experimental data are compared with spherical shell model calculations in the full pf-shell.Comment: 9 pages, RevTeX, 7 figures include

Spectroscopic factors for bound s-wave states derived from neutron scattering lengths

A simple and model-independent method is described to derive neutron single-particle spectroscopic factors of bound s-wave states in $^{A+1}Z = ^{A}Z \otimes n$ nuclei from neutron scattering lengths. Spectroscopic factors for the nuclei ^{13}C, ^{14}C, ^{16}N, ^{17}O, ^{19}O, ^{23}Ne, ^{37}Ar, and ^{41}Ar are compared to results derived from transfer experiments using the well-known DWBA analysis and to shell model calculations. The scattering length of ^{14}C is calculated from the ^{15}C_{g.s.} spectroscopic factor.Comment: 9 pages (uses revtex), no figures, accepted for publication in PRC, uuencoded tex-files and postscript-files available at ftp://is1.kph.tuwien.ac.at/pub/ohu/Thermal.u

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Background: The combination of BRAF and MEK inhibitors has become standard of care in the treatment of metastatic BRAF V600-mutated melanoma. Clinical factors for an early prediction of tumor response are rare. The present study investigated the association between the development of an early exanthema induced by vemurafenib or vemurafenib plus cobimetinib and therapy outcome. Methods: This multicenter retrospective study included patients with BRAF V600-mutated irresectable AJCC-v8 stage IIIC/D to IV metastatic melanoma who received treatment with vemurafenib (VEM) or vemurafenib plus cobimetinib (COBIVEM). The development of an early exanthema within six weeks after therapy start and its grading according to CTCAEv4.0 criteria was correlated to therapy outcome in terms of best overall response, progression-free (PFS), and overall survival (OS). Results: A total of 422 patients from 16 centers were included (VEM, n=299; COBIVEM, n=123). 20.4% of VEM and 43.1% of COBIVEM patients developed an early exanthema. In the VEM cohort, objective responders (CR/PR) more frequently presented with an early exanthema than non-responders (SD/PD); 59.0% versus 38.7%; p=0.0027. However, median PFS and OS did not differ between VEM patients with or without an early exanthema (PFS, 6.9 versus 6.0 months, p=0.65; OS, 11.0 versus 12.4 months, p=0.69). In the COBIVEM cohort, 66.0% of objective responders had an early exanthema compared to 54.3% of non-responders (p=0.031). Median survival times were significantly longer for patients who developed an early exanthema compared to patients who did not (PFS, 9.7 versus 5.6 months, p=0.013; OS, not reached versus 11.6 months, p=0.0061). COBIVEM patients with a mild early exanthema (CTCAEv4.0 grade 1-2) had a superior survival outcome as compared to COBIVEM patients with a severe (CTCAEv4.0 grade 3-4) or non early exanthema, respectively (p=0.047). This might be caused by the fact that 23.6% of patients with severe exanthema underwent a dose reduction or discontinuation of COBIVEM compared to only 8.9% of patients with mild exanthema. Conclusions: The development of an early exanthema within 6 weeks after treatment start indicates a favorable therapy outcome upon vemurafenib plus cobimetinib. Patients presenting with an early exanthema should therefore be treated with adequate supportive measures to provide that patients can stay on treatment